ReviewTranslational psychiatry2024
Applications of OPM-MEG for translational neuroscience: a perspective.
Review in Translational psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Noninvasive decoding of typed sentences from human brain activity.Nature neuroscience · 2026Article
- SERF-MEG as a Functional Biomarker of Optic Nerve Injury: Agreement and Correlation with Visual Evoked Potentials.Bioengineering (Basel, Switzerland) · 2026Article
- Optically pumped magnetometers enhance neuroimaging performance-An EEG, OPM, and SQUID-MEG study.iScience · 2026Article
- Optimizing OPM-MEG Sensor Layouts Using the Sequential Selection Algorithm with Simulated Sources and Individual Anatomy.Sensors (Basel, Switzerland) · 2026Article
- A two-person neuroscience perspective on parent-infant dyadic expansion of consciousness.Frontiers in human neuroscience · 2026Article
- Magnetoencephalography biomarkers for assessing myelin content and neuronal function in acute optic neuritis.Brain communications · 2026Article
- Magnetoencephalography study of the Xingnao Kaiqiao acupuncture during acupuncture and language task states in healthy volunteers: a single-blind, randomized, sham-controlled trial protocol.Frontiers in neurology · 2026Article
- Differential resting-state MEG microstate patterns in migraineurs: a cross-sectional study.The journal of headache and pain · 2025Article
- Oscillatory and evoked neural responses underlying gating in the primary somatosensory cortices: Evidence from optically-pumped magnetometry.NeuroImage · 2025Article
- Multimodal quantitative analysis guides precise preoperative localization of epilepsy.Journal of neurology · 2025Review
- Superconducting Quantum Magnetometers for Brain Investigations.Sensors (Basel, Switzerland) · 2025Review
- Assessing the stability of evoked, induced, and passive MEG responses for repeat testing with optically pumped magnetometers.Scientific reports · 2025Article
- Using Wearable MEG to Study the Neural Control of Human Stepping.Sensors (Basel, Switzerland) · 2025Article
- Optimization of OPM-MEG Layouts with a Limited Number of Sensors.Sensors (Basel, Switzerland) · 2025Article
- Influence of Atomic Magnetometer's Orientation on Its Frequency Response.Sensors (Basel, Switzerland) · 2025Article
- Hallmarks of Brain Plasticity.Biomedicines · 2025Review
- From early to contemporary normative modeling: Mapping individual differences in neurophysiological signals.Imaging neuroscience (Cambridge, Mass.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Magnetoencephalography (MEG) allows the non-invasive measurement of brain activity at millisecond precision combined with localization of the underlying generators. So far, MEG-systems consisted of superconducting quantum interference devices (SQUIDS), which suffer from several limitations. Recent technological advances, however, have enabled the development of novel MEG-systems based on optically pumped magnetometers (OPMs), offering several advantages over conventional SQUID-MEG systems. Considering potential improvements in the measurement of neuronal signals as well as reduced operating costs, the application of OPM-MEG systems for clinical neuroscience and diagnostic settings is highly promising. Here we provide an overview of the current state-of-the art of OPM-MEG and its unique potential for translational neuroscience. First, we discuss the technological features of OPMs and benchmark OPM-MEG against SQUID-MEG and electroencephalography (EEG), followed by a summary of pioneering studies of OPMs in healthy populations. Key applications of OPM-MEG for the investigation of psychiatric and neurological conditions are then reviewed. Specifically, we suggest novel applications of OPM-MEG for the identification of biomarkers and circuit deficits in schizophrenia, dementias, movement disorders, epilepsy, and neurodevelopmental syndromes (autism spectrum disorder and attention deficit hyperactivity disorder). Finally, we give an outlook of OPM-MEG for translational neuroscience with a focus on remaining methodological and technical challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.